Proactive Costs of Care support for people with gynecologic cancer
Official title: An Open, Single-arm, Single-site Study to Evaluate the Proactive Costs of Care (PCOC) Intervention Delivered by a Trained Lay Educator to Test Feasibility With the Goal of Improving Self-efficacy Among Patients With Gynecologic Cancer on Active Therapy and Their Caregivers
Run by Cedars-Sinai Medical Center · NCT07217262 · Data updated 2026-11-12
This one-time, 30-minute educational session tries to help adults with gynecologic cancer (or their caregivers) who are starting a new systemic therapy learn to track medical costs, understand insurance and resources, and reduce financial stress.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 36 (estimated) |
| Sponsor | Cedars-Sinai Medical Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | December 22, 2025 |
| Main results expected | April 2027 |
| Study ends | April 2027 |
| Registry record updated | February 10, 2026 |
| Trial ID | NCT07217262 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with gynecologic cancer who are on active systemic therapy within 30 days of enrollment, receiving care at Cedars‑Sinai Medical Center, English-speaking, or their caregivers are ideal candidates.
✕Probably not a fit
People who do not speak or read English, are not receiving care at Cedars‑Sinai, are not on active systemic therapy, or are unwilling to complete the session and surveys are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Proactive Costs of Care (PCOC) intervention is a single approximately 30-minute session led by a lay educator who reviews a Proactive Costs of Care Guide and a Cost Tracker; materials are available on paper or electronically. The session can be delivered in person, by video, or by phone to patients with gynecologic cancers who are starting systemic therapy and to their caregivers at Cedars‑Sinai. Participants complete a baseline survey before the intervention and a follow-up survey three months later to measure completion, confidence in solving cost-related problems, health insurance literacy, and financial distress. The main goal is to measure feasibility (completion rate), with secondary interest in changes in confidence and financial distress.
Why it matters
Potential benefit: If successful, this could help patients and caregivers feel more confident managing insurance, employment, and out-of-pocket medical costs and reduce financial distress.
How similar studies have gone: Prior financial-navigation and educational interventions have shown modest improvements in financial distress and patient confidence in some settings, but results vary and this specific guide/tracker combination is a newer approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for Patient Participants: * Individuals 18 years old or older are included. * Individuals diagnosed with gynecologic cancer * On active systemic therapy within 30 days of enrollment * Receiving treatment at Cedars-Sinai Medical Center * Can speak, read, and understand English Inclusion Criteria for Caregiver Participants: \- Caregivers to patients who satisfy the criteria above Exclusion Criteria for Patient and Caregiver Participants: * Any patients whose records are flagged "break the glass" or "research opt out." * Cannot speak, read, or understand English * Not willing to participate in the intervention or complete surveys
Where it's running
-
Cedars-Sinai Medical Center
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Margaret Liang, MD, MS — Cedars-Sinai Medical Center
- Study coordinator: Shu-Fan Chen, BS
- Email: Shu-Fan.Chen@cshs.org
- Phone: (323) 413-7804
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Immunonutrition and Brain Monitoring to See if Delirium Happens After Gynecologic Cancer Surgery
This study tests whether a preoperative immunonutrition scoring plus intraoperative brain monitoring can help predict or relate to postoperative delirium in women aged 65 and older undergoing major gynecologic cancer surgery.
-
Lived Experience Narratives in Dementia
This project tests a digital Online LEND Intervention that shares dementia patients’ and caregivers’ lived experiences to see if it helps wellbeing and connection.
-
Prophylactic subcutaneous drainage after gynecologic cancer surgery
This study tests whether placing a small drain under the skin after gynecologic cancer surgery helps prevent wound problems in women with thicker tissue under the skin.
-
Feasibility of high-dose multimodal prehabilitation for women awaiting gynecologic cancer surgery
This study tests whether a high-dose, multimodal prehabilitation program can be delivered before gynecologic cancer surgery and whether patients prefer in-person, remote, or education-only approaches.
-
Romiplostim N01 plus ATRA for persistent chemotherapy-induced low platelets after remission from gynecologic, breast, or lung cancer
This trial tests whether adding ATRA to Romiplostim N01 helps people keep a safe platelet count after finishing chemotherapy for certain cancers.
-
Sexual well-being in people treated for gynecologic cancer and their partners
This project will follow people with gynecologic cancer and their partners to see if their sexual function changes over time using questionnaires and brief exams.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.